Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Johannes Schwarz, Wolfgang H. Oertel et al.|The Lancet Neurology|2019Cited by 126
Less Is More – Estimation of the Number of Strides Required to Assess Gait Variability in Spatially Confined SettingsDaniel Kroneberg, Tanja Schmitz‐Hübsch, Morad Elshehabi et al.|Frontiers in Aging Neuroscience|2019Cited by 73